This video screenshot shows a volunteer receiving a polyvalent vector vaccine for Covid-19 made in Russia as part of clinical studies at the Sechenov First Moscow State Medical University.
Press Office of the Medical University of Sechenov | TASS | Getty Images
Russia has announced that human trials of its controversial coronavirus vaccine have started in the United Arab Emirates (UAE).
The Kremlin said on Monday that Russian President Vladimir Putin had called the Crown Prince of Abu Dhabi, Sheikh Mohammed bin Zayed al-Nahyan.
During the call, the “importance of joint efforts to combat the spread of the coronavirus, including interaction with the Russian Sputnik V vaccine currently undergoing clinical testing in the UAE” was noted. said the Kremlin in a statement. She added that the heads of state and government “reaffirmed their mutual readiness to further strengthen the strategic partnership between Russia and the United Arab Emirates in various areas”.
The United Arab Emirates are the second foreign country to have tested the Russian vaccine “Sputnik V”, named with an allusion to the Cold War space race, after testing in Belarus, Reuters reported on Monday. More lawsuits are reported to begin in Venezuela, another Russian allied country.
Even so, Russia’s vaccine is controversial as experts around the world question its effectiveness and safety.
The Russian Gamaleya Research Institute of Epidemiology and Microbiology, which developed the vaccine, has not yet shared additional research and data from early clinical trials testing the vaccine. The Moscow Times reported last week. It happens despite the request of scientists Beware of the published data in The Lancet Medical Journal in September.
Russian officials have said claims that the vaccine is not effective are synonymous “Information war” and reflect Western bias towards the country. The vaccine received regulatory approval in August. This makes Russia the first country in the world to have reached this stage.
Russia had already announced his website dedicated to the vaccine Several countries, including the United Arab Emirates, as well as the Philippines, Saudi Arabia and “possibly India and Brazil”, would participate in “post-registration clinical trials” of the vaccine. Mass production should start in September 2020, but it is uncertain whether this has started or not.